Inflammation

Identifying which patients respond quickly to dietary therapies for Crohn’s disease may help indicate which ones will succeed long term and which ones might do better on a different therapy, according to study results.

CytoSorbents Corp. announced that its blood purification technology for the treatment of deadly inflammation and cytokine storm has been granted Emergency Use Authorization by the FDA for patients with COVID-19.

Exposure to ambient particulate matter less than 2.5 µm may affect CV benefits from intensive BP lowering, according to a post hoc analysis of the SPRINT trial presented at the American College of Cardiology Scientific Session.

We have come to the third and final installment in our spontaneous series about outer retinal anomalies found on OCT: focal choroidal excavations.

KOLOA, Hawaii — At Hawaiian Eye 2020, John A. Hovanesian, MD, clinical instructor at the UCLA Jules Stein Eye Institute, gives his presentation on the latest steroid delivery options that allow patients to avoid drops after cataract surgery for the treatment of inflammation.

ATLANTA – A discussion with patients about their current dietary habits and nutritional supplementation can help the optometrist customize a dry eye treatment plan, according to a speaker here at SECO.

The cover story in this issue of Ocular Surgery News focuses on noninfectious uveitis and new treatments that help control inflammation. Some of them, like Yutiq from EyePoint Pharmaceuticals and Ozurdex from Allergan, deliver anti-inflammatories inside the eye — an appealing approach because of the slow release of drug and the elimination of compliance issues. But of course, eye drops are used to treat most conditions in our specialty, and we know patients consistently fail to take them well. This is a bigger problem than most of us would like to acknowledge, yet few of us make the effort to educate patients on how to take drops. We would all be better doctors if we did.

Cosmetic iris implants are non-FDA-approved procedures that can result in severe, potentially blinding complications.

MIAMI BEACH, Fla. — JAK inhibitors are being studied to treat patients with psoriasis and atopic dermatitis, with many showing promising outcomes, according to a presenter at South Beach Symposium.

Among patients with ACS, periprocedural loading doses of atorvastatin before planned PCI did not reduce MACE at 12 months compared with placebo, according to new data from the SECURE-PCI trial.